NCT07189624View on ClinicalTrials.gov

Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2029

Conditions
Cirrhosis With Hepatocellular Carcinoma
Interventions
OTHER

Exercise

30-minutes exercise on a bicycle with heart rate monitor and gas exchange analyzer.

Trial Locations (2)

63003

Chu Estaing Medecine Digestive Et Hepatobiliaire, Clermont-Ferrand

Unknown

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT07189624 - Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter